Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?

BACKGROUND: Denosumab is an inhibitor of monoclonal receptor activator of nuclear factor-ĸB ligand, approved to treat giant cell tumors of bone (GCTB). It is commonly used for unresectable tumors and for downstaging the tumor to perform less-morbid procedures. Although denosumab has been used extens...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Orthop Relat Res
Egile Nagusiak: Hindiskere, Suraj, Errani, Costantino, Doddarangappa, Srinath, Ramaswamy, Veena, Rai, Mayur, Chinder, Pramod S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer 2020
Gaiak:
Selected Proceedings of the 2019 International Society of Limb Salvage Annual Meeting (Guest Editor: John H. Healey, Md)
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594929/
https://ncbi.nlm.nih.gov/pubmed/32401001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CORR.0000000000001285
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak